Introduction
Mebhydrolin napadisylate is an antihistamine used for the relief of allergic symptoms such as rhinitis, urticaria, and conjunctivitis. It is a second-generation antihistamine that provides effective relief from symptoms associated with allergic reactions without the sedative effects often seen with first-generation antihistamines.
Uses
Mebhydrolin napadisylate is used to manage symptoms of allergic conditions including:
- Allergic rhinitis
- Chronic urticaria (hives)
- Allergic conjunctivitis
- Other allergic skin conditions
| Brand Name | Mebidal |
|---|---|
| Type | Tablet |
| Weight | 50 mg |
| Generic | Mebhydrolin Napadisylate |
| Manufacturer | Eskayef Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Mebhydrolin napadisylate works by selectively blocking H1 histamine receptors. This inhibition prevents histamine from binding to these receptors, thereby reducing the symptoms of allergic reactions such as itching, swelling, and redness. By blocking histamine action, it helps in alleviating allergic symptoms effectively.
How Long Does It Take to Work?
Typically, mebhydrolin napadisylate begins to work within 1 to 2 hours after oral administration. The peak effect is usually observed within 3 to 4 hours, providing symptomatic relief from allergic reactions.
Absorption
Mebhydrolin napadisylate is well-absorbed after oral administration. It reaches peak plasma concentrations within 1 to 2 hours. The presence of food does not significantly affect its absorption.
Route of Elimination
The drug is primarily metabolized in the liver, with metabolites excreted in the urine. A small fraction of the drug is eliminated unchanged in the feces.
Dosage
Adults and children over 10 years: 2-6 tablets dailyChildren-
- 5-10 years: 2-4 tablets daily
- 2-5 years: 1-3 tablets daily
- Up to 2 years: 1-2 tablets daily
The recommended dosage of mebhydrolin napadisylate may vary depending on the condition being treated. Generally, the dosage for adults and children over 12 years is:
- 10 to 20 mg once or twice daily, as prescribed by a healthcare provider.
Dosage for children under 12 years should be determined by a healthcare provider based on individual needs and response to treatment.
Administration
Mebhydrolin napadisylate is administered orally in the form of tablets or capsules. It should be taken with or without food as directed by the healthcare provider. Adhere to the prescribed dosage and administration instructions.
Side Effects
Common side effects may include:
- Drowsiness
- Dizziness
- Dry mouth
- Headache
Serious side effects are rare but may include severe allergic reactions or prolonged drowsiness. If any severe symptoms occur, seek medical attention promptly.
Toxicity
Signs of toxicity may include excessive drowsiness, confusion, or difficulty breathing. In case of overdose or severe side effects, discontinue use and seek immediate medical assistance.
Precautions
Precautions include:
- Use with caution in individuals with a history of liver or kidney disease.
- Avoid alcohol and other central nervous system depressants while using mebhydrolin napadisylate.
- Monitor for signs of drowsiness or impaired coordination.
Interaction
Mebhydrolin napadisylate may interact with other medications, particularly those affecting the central nervous system. Inform your healthcare provider of all medications and supplements you are taking.
Disease Interaction
Use mebhydrolin napadisylate cautiously in patients with liver or kidney disease. It may require dose adjustment or careful monitoring in these cases.
Drug Interaction
Potential drug interactions include:
- Alcohol and other CNS depressants, which may enhance sedative effects.
- Other antihistamines or medications with anticholinergic properties.
- Drugs affecting liver enzymes that may alter the metabolism of mebhydrolin napadisylate.
Food Interactions
Food intake does not significantly affect the absorption of mebhydrolin napadisylate. It can be taken with or without food.
Pregnancy Use
Mebhydrolin napadisylate should be used during pregnancy only if clearly needed and if the benefits outweigh the risks. Consult a healthcare provider before use during pregnancy.
Lactation Use
The use of mebhydrolin napadisylate during lactation is not well-studied. It is advisable to consult a healthcare provider before using the medication while breastfeeding.
Acute Overdose
In the case of acute overdose, symptoms may include severe drowsiness, confusion, and agitation. Seek immediate medical attention if overdose is suspected.
Contraindication
Mebhydrolin napadisylate is contraindicated in individuals with known hypersensitivity to the drug or any of its components. It should also be used cautiously in individuals with certain medical conditions, as advised by a healthcare provider.
Use Direction
Follow the prescribed dosage instructions carefully. Do not exceed the recommended dose and avoid missing doses. If a dose is missed, take it as soon as possible unless it is almost time for the next dose. Do not double up on doses.
Storage Conditions
Store mebhydrolin napadisylate at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Volume of Distribution
The volume of distribution of mebhydrolin napadisylate indicates that it is distributed throughout the body, with a moderate affinity for tissues involved in allergic reactions.
Half Life
The half-life of mebhydrolin napadisylate is approximately 8 to 12 hours, supporting the need for once or twice-daily dosing.
Clearance
Mebhydrolin napadisylate is cleared from the body primarily through the liver and kidneys. The clearance rate may be affected by liver or renal function, and dosage adjustments may be necessary for patients with impaired liver or kidney function.
See in details version Mebidal Tablet 50 mg also Mebidal Tablet 50 mg in bangla
Social card
